Save the date!

Clinical Genomes Scotland - 7th September 2026

Please join colleagues from academia, industry and healthcare at the Royal College of Physicians of Edinburgh to review advances in genome technology and informatics, to discuss how genomic testing can be deployed in Scotland to optimise patient care for cancer and rare diseases.

The meeting will review and discuss the latest advances in genome sequencing technology, informatics and their clinical applications for patients in Scotland.

Key areas for discussion will include the use of genome-based testing to support care for patients with cancer and rare genetic disorders, emphasising innovation and collaboration between academia, healthcare specialists, government, and the biotechnology and pharmaceutical industries. 

Confirmed Speakers

  • Dr Ellen Thomas (Genomics England)
  • Professor Sir Munir Pirmohamed (University of Liverpool)
  • Professor Zosia Miedzybrodzka (University of Aberdeen)
  • Dr Eve Miller-Hodges (School of Neuroscience and Cardiovascular Sciences, University of Edinburgh)
  • Professor Pleasantine Mill (Institute of Genetics and Cancer, University of Edinburgh)
  • Professor Patricia Roxburgh (University of Glasgow)
  • Professor Mike Hubank (Institute of Cancer Research)
  • Dr Ultan McDermott (AstraZeneca)
  • Professor Ian Simpson (School of Informatics, University of Edinburgh)
  • Panel discussion, chaired by Professor Kenny Baillie, featuring Dr Jonathan Berg, Natalie Frankish, Professor Charlie Gourley, Dr Ellen Thomas, Professor Sir Munir Pirmohamed, and Dr Paul Westwood.

Sponsored Talks by: Congenica, Element Biosciences, Illumina, Oxford Nanopore, Pacific Biosciences, Roche and Ultima Genomics.

The meeting is hosted by One Health Genomics Edinburgh, and is sponsored by Centogene, Congenica, Element Biosciences, Illumina, Oxford Nanopore, Pacific Biosciences, Roche, Sophia Genetics and Ultima Genomics.

Organising Committee: Tim Aitman, Charlie Gourley, Zosia Miedzybrodzka, Eve Miller-Hodges, David Moore, Lee Murphy, Patricia Roxburgh, Daniel Toddie-Moore, Joris Veltman

Clinical Genomes Scotland banner

This article was published on